Corvus Pharma Participates In New $13.5M Financing For Angel Pharmaceuticals
Corvus Pharmaceuticals Inc CRVS
$11.91
โผ -0.75%
($-0.09)
Open
$12.36
Prev Close
$12.00
Day Range
$11.73 โ $12.58
52W Range
$3.55 โ $26.95
Market Cap
$1.00B
Beta
0.96
EPS (TTM)
$-0.53
๐ Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2016-03-23 |
| Shares Out. | 84,090,000 |
| Website | corvuspharma.com/ โ |
| Phone | 13026587581 |
Corvus Pharmaceuticals Inc is a publicly traded company under the ticker symbol CRVS on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
๐ Analyst Ratings
13 analysts (2026-06-01)
